HER3 is a determinant for poor prognosis in melanoma

Reschke, M.; Mihic-Probst, D.; van der Horst, E. H.; Knyazev, P.; Wild, P. J.; Hutterer, M.; Meyer, S.; Dummer, R.; Moch, H.; Ullrich, A.

Local TagsRelease HistoryDetailsSummary

HER3 is a determinant for poor prognosis in melanoma

Reschke, M., Mihic-Probst, D., van der Horst, E. H., Knyazev, P., Wild, P. J., Hutterer, M., et al. (2008). HER3 is a determinant for poor prognosis in melanoma. Clinical Cancer Research, 14(16), 5188-5197.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-0010-5C20-F Version Permalink: https://hdl.handle.net/11858/00-001M-0000-0010-5C21-D

Genre: Journal Article

Alternative Title : Clin. Cancer Res.

Files

show Files

Locators

show

Creators

show

hide

Creators:
Reschke, M.¹, Author
Mihic-Probst, D., Author
van der Horst, E. H.², Author
Knyazev, P.¹, Author
Wild, P. J., Author
Hutterer, M., Author
Meyer, S., Author
Dummer, R., Author
Moch, H., Author
Ullrich, A.¹, Author

Affiliations:
1Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565172
2External Organizations, ou_persistent22

Content

show

Details

show

hide

Language(s): eng - English

Dates: Date issued: 2008-08-15

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: Peer

Identifiers: eDoc: 377513
ISI: 000258523800024

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: Clinical Cancer Research

Alternative Title : Clin. Cancer Res.

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: -

Pages: - Volume / Issue: 14 (16) Sequence Number: - Start / End Page: 5188 - 5197 Identifier: ISSN: 1078-0432